A homegrown coronavirus vaccine will be rolled out in India from today even though clinical trials haven't been completed. But the government insists it will be safe and effective. The All India Drug Action Network (AIDAN), an independent watchdog, led a chorus of concern from experts saying it was "shocked" and "baffled" by the emergency approval of Covaxin, developed by
The government procurement price of Rs 200 per dose for Covishield, manufactured by Serum Institute, is higher than what the EU is said to be paying. The EU is paying euro 1.78 per dose (nearly Rs 159) for the Oxford/AstraZeneca vaccine.
India Prepares For Massive Vaccine Drive, But Some Fear It s Moving Too Quickly – Nation & World News wuft.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wuft.org Daily Mail and Mail on Sunday newspapers.
Scientists, public health experts and opposition politicians have raised questions about one of the two vaccines the country of 1.4 billion people has authorized for emergency use against COVID-19.
The Straits Times
We weren’t told we were part of trial, say test subjects in India
A medic administers Covaxin to a health worker during its trials in Ahmedabad, India, on Nov 26, 2020.PHOTO: REUTERS
PublishedJan 12, 2021, 3:00 pm SGT
https://str.sg/JDyi
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.